Search

The strategic framework agreement deepens the long-standing partnership, leveraging Artificial Intelligence and High-Performance Computing to identify new opportunities of collaboration in the

The event, organized by AseBio and the Salamanca City Council, was held this Tuesday at the Congress and Exhibition Center of the Tormes capital. It brought together 120 attendees from 75

We interviewed Germán Alejandro Sánchez Martín, Founder & CEO of Opportunity Health, the company that won the BIOSPAIN 2025 Pitch Presentation.

The announcement was made during the Spain–United States Business Meeting held in Boston, organized by ICEX España Exportación e Inversiones, with the participation of 40 Spanish companies and nearly

Meet Atlas Molecular Pharma, our new member. We spoke with Susana Castel, CEO.

The event brought together experts from hospitals, research organizations, industry and innovation ecosystems to co-create sustainable service models for the Paediatric Health Data Space (PHDS).

At AseBio, we believe this Executive Order creates uncertainty for the European biotechnology sector—especially for companies exporting to the U.S.—and we will continue working to help our member

The company received the recognition from the Ministry of Industry, presented by King Felipe VI, for its commitment to biotechnological innovation, industrial capacity and strengthening Europe’s

HIPRA Biotech Services reaches key milestones in its first year of operations, including signing its first agreement in just nine months and advancing new collaboration opportunities with European

The Kadans Tech Summit is an exclusive event bringing together European deep tech companies, technology leaders, academics and researchers.

Biobide, a subsidiary of Biotechnology Assets (BME Growth: BST), has obtained two Good Laboratory Practice (GLP) certifications granted by ENAC for chemicals, food additives and plant protection

Antonio Delgado participated in the panel “ From lab to fab: enabling scale up of bio-based innovations”

We consider a Biotech Act II that improves coordination, facilitates market access, and accelerates industrial development to be key in transforming European scientific potential into economic

BCN HEALTH has published the study “Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness” in ESC Heart Failure, a peer-reviewed journal of the European

The city of Salamanca reinforces its position as a strategic enclave for the bioeconomy and agri-food innovation in Castilla y León, hosting a meeting that aims to place the territory on the European

InceptionBio is a new €100 million target-size fund focused on biotech company creation and early-stage projects, with a strong focus on Spain.

Josep Samitier, a leading figure in bioengineering and nanomedicine, reflects on the key milestones of his time at the helm of IBEC and discusses the challenges facing the biotech ecosystem in Spain

Covers the use of vafidemstat for treating non-aggressive symptoms of Borderline Personality Disorder (BPD).

Aptadel Therapeutics advances in its treatment for Ewing's sarcoma after closing a bridge round of 2 million euros.

According to WHO and ECDC data, 161,569 cases were reported in 2024 across 51 of the 53 countries in the European region, equivalent to 17.2 cases per 100,000 inhabitants.

Recent data from an ongoing study in first-line AML showed a 100% overall response rate (ORR) with iadademstat in combination with venetoclax and azacitidine.